104 related articles for article (PubMed ID: 22951630)
1. Tenofovir use and pregnancy among women initiating HAART.
Maskew M; Westreich D; Firnhaber C; Sanne I
AIDS; 2012 Nov; 26(18):2393-7. PubMed ID: 22951630
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P;
PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543
[TBL] [Abstract][Full Text] [Related]
3. Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.
Myer L; Kamkuemah M; Kaplan R; Bekker LG
Trop Med Int Health; 2013 Nov; 18(11):1400-5. PubMed ID: 24102663
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral vaginal gel shows promise against HIV.
Baleta A
Lancet; 2010 Jul; 376(9738):320. PubMed ID: 20681062
[No Abstract] [Full Text] [Related]
5. Impact of choice of NRTI in first-line antiretroviral therapy: a cohort analysis of stavudine vs. tenofovir.
Brennan AT; Shearer K; Maskew M; Long L; Sanne I; Fox MP
Trop Med Int Health; 2014 May; 19(5):490-8. PubMed ID: 24589363
[TBL] [Abstract][Full Text] [Related]
6. Incident pregnancy and time to death or AIDS among HIV-positive women receiving antiretroviral therapy.
Westreich D; Maskew M; Evans D; Firnhaber C; Majuba P; Sanne I
PLoS One; 2013; 8(3):e58117. PubMed ID: 23520489
[TBL] [Abstract][Full Text] [Related]
7. The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1.
Patel K; Van Dyke RB; Mittleman MA; Colan SD; Oleske JM; Seage GR;
AIDS; 2012 Oct; 26(16):2027-37. PubMed ID: 22781228
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.
Kalayjian RC; Lau B; Mechekano RN; Crane HM; Rodriguez B; Salata RA; Krishnasami Z; Willig JH; Martin JN; Moore RD; Eron JJ; Kitahata MM
AIDS; 2012 Sep; 26(15):1907-15. PubMed ID: 22824630
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa.
Skhosana L; Steegen K; Bronze M; Lukhwareni A; Letsoalo E; Papathanasopoulos MA; Carmona SC; Stevens WS
PLoS One; 2015; 10(2):e0118145. PubMed ID: 25659108
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapies in women after single-dose nevirapine exposure.
Lockman S; Hughes MD; McIntyre J; Zheng Y; Chipato T; Conradie F; Sawe F; Asmelash A; Hosseinipour MC; Mohapi L; Stringer E; Mngqibisa R; Siika A; Atwine D; Hakim J; Shaffer D; Kanyama C; Wools-Kaloustian K; Salata RA; Hogg E; Alston-Smith B; Walawander A; Purcelle-Smith E; Eshleman S; Rooney J; Rahim S; Mellors JW; Schooley RT; Currier JS;
N Engl J Med; 2010 Oct; 363(16):1499-509. PubMed ID: 20942666
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects of tenofovir use in HIV-infected pregnant women and their infants.
Nurutdinova D; Onen NF; Hayes E; Mondy K; Overton ET
Ann Pharmacother; 2008 Nov; 42(11):1581-5. PubMed ID: 18957630
[TBL] [Abstract][Full Text] [Related]
12. Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil.
Pilotto JH; Velasque LS; Friedman RK; Moreira RI; Veloso VG; Grinsztejn B; Morgado MG; Watts DH; Currier JS; Hoffman RM
Antivir Ther; 2011; 16(3):349-56. PubMed ID: 21555817
[TBL] [Abstract][Full Text] [Related]
13. Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine.
Havlir DV; Koelsch KK; Strain MC; Margot N; Lu B; Ignacio CC; Miller MD; Wong JK;
J Infect Dis; 2005 Apr; 191(7):1164-8. PubMed ID: 15747253
[TBL] [Abstract][Full Text] [Related]
14. Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings?
Labhardt ND; Bader J; Lejone TI; Ringera I; Puga D; Glass TR; Klimkait T
Trop Med Int Health; 2015 Jul; 20(7):914-8. PubMed ID: 25782332
[TBL] [Abstract][Full Text] [Related]
15. Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.
Barrios A; Negredo E; Domingo P; Estrada V; Labarga P; Asensi V; Morales D; Santos J; Clotet B; Soriano V;
Antivir Ther; 2005; 10(7):825-32. PubMed ID: 16312178
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy and virologic response to antiretroviral therapy in South Africa.
Westreich D; Cole SR; Nagar S; Maskew M; van der Horst C; Sanne I
PLoS One; 2011; 6(8):e22778. PubMed ID: 21829650
[TBL] [Abstract][Full Text] [Related]
17. [Introduction. Tenofovir].
Mallolas J
Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():1. PubMed ID: 19195430
[No Abstract] [Full Text] [Related]
18. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.
Abdool Karim Q; Abdool Karim SS; Frohlich JA; Grobler AC; Baxter C; Mansoor LE; Kharsany AB; Sibeko S; Mlisana KP; Omar Z; Gengiah TN; Maarschalk S; Arulappan N; Mlotshwa M; Morris L; Taylor D;
Science; 2010 Sep; 329(5996):1168-74. PubMed ID: 20643915
[TBL] [Abstract][Full Text] [Related]
19. [Immunological effectiveness of the nucleoside/nucleotide analog combinations, tenofovir + lamivudine, didanosine + lamivudine and tenofovir + didanosine, in patients with HIV infection and sustained viral suppression].
Cervero M; Torres R; Jusdado JJ; Rodríguez-Rosado R; Del Alamo M; García-Benaya E
Enferm Infecc Microbiol Clin; 2006; 24(7):426-30. PubMed ID: 16956530
[TBL] [Abstract][Full Text] [Related]
20. Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.
Chi BH; Ellis GM; Chintu N; Cantrell RA; Sinkala M; Aldrovandi GM; Warrier R; Mbewe F; Nakamura K; Stringer EM; Frenkel LM; Stringer JS
AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1099-106. PubMed ID: 19886836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
